TickerFacts.

Company research / TFX

Teleflex Inc (TFX)

Build a valuation ↗↓ Download CSV

SEC name TELEFLEX INC · CIK 0000096943 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Teleflex Inc reported revenue of $1.99B. Revenue grew 17.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

56.2%
Gross margin
5.9%
Operating margin
-45.4%
Net margin
-29.0%
Return on year-end equity
17.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-10

Headquarters locality: Wayne · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/a$1.99B$1.70B$1.71B$2.79B$2.81B$2.54B$2.60B$2.45B$2.15B$1.87B
Cost of Revenuen/a$871.96M$662.16M$672.33M$1.26B$1.26B$1.21B$1.19B$1.15B$974.50M$871.83M
Gross Profitn/a$1.12B$1.04B$1.04B$1.53B$1.55B$1.32B$1.41B$1.30B$1.17B$996.20M
R&D Expensen/a$144.78M$109.02M$113.63M$153.82M$130.84M$119.75M$113.86M$106.21M$84.77M$58.58M
Operating Incomen/a$118.37M$103.65M$258.73M$499.73M$628.10M$423.07M$427.25M$321.70M$372.28M$319.45M
Depreciation & Amortizationn/a$177.74M$161.53M$148.10M$230.59M$237.36M$227.25M$218.37M$214.71M$160.34M$128.35M
EBITDAn/a$296.11M$265.19M$406.83M$730.32M$865.46M$650.32M$645.62M$536.42M$532.62M$447.80M
Net Income-$1.03B-$905.64M$69.67M$356.33M$363.14M$485.37M$335.32M$461.47M$200.80M$152.53M$237.38M
EPS (Diluted)n/a-$20.25$1.48$7.53$7.68$10.23$7.09$9.80$4.29$3.27$4.98
Total Assets$6.79B$6.95B$7.10B$7.53B$6.93B$6.87B$7.15B$6.31B$6.28B$6.18B$3.89B
Total Liabilities$3.88B$3.82B$2.82B$3.09B$2.91B$3.12B$3.82B$3.33B$3.74B$3.75B$1.75B
Long-Term Debt$2.81B$2.64B$1.66B$1.82B$1.71B$1.85B$2.48B$1.91B$2.16B$2.25B$1.03B
Shareholders' Equity$2.90B$3.12B$4.28B$4.44B$4.02B$3.75B$3.34B$2.98B$2.54Bn/a$2.14B
Cash & Equivalents$300.16M$378.56M$247.85M$222.85M$292.03M$445.08M$375.88M$301.08M$357.16M$333.56M$543.79M
Operating Cash Flown/a$96.68M$301.88M$206.14M$342.81M$652.14M$437.14M$437.07M$435.09M$426.30M$410.59M
Capital Expendituresn/a$95.24M$90.44M$46.42M$79.19M$71.62M$90.69M$102.69M$80.80M$70.90M$53.13M
Free Cash Flown/a$1.45M$211.44M$159.72M$263.62M$580.52M$346.45M$334.37M$354.29M$355.40M$357.45M
Share Repurchases$250.00M$300.00M$200.00M$0$0n/an/an/an/an/an/a
Dividends Paid$59.88M$60.27M$63.54M$63.90M$63.79M$63.65M$63.22M$62.83M$62.16M$61.24M$58.96M
Dividends Per Sharen/a$1.36$1.36$1.36$1.36$1.36$1.36$1.36$1.36$1.36$1.36
Weighted Average Diluted Sharesn/a44.72M47.09M47.30M47.31M47.43M47.29M47.09M46.80M46.66M47.65M
EPS (Basic)n/a-$20.30$1.49$7.58$7.74$10.38$7.21$9.99$4.39$3.39$5.48

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView